Chinese english Germany Japanese Korea

1-Piperazinecarboxylic acid, 2,3-dimethyl-, 1,1-dimethylethyl ester, (2S,3R)-

1-Piperazinecarboxylic acid, 2,3-dimethyl-, 1,1-dimethylethyl ester, (2S,3R)- Struktur
1932164-94-7
CAS-Nr.
1932164-94-7
Englisch Name:
1-Piperazinecarboxylic acid, 2,3-dimethyl-, 1,1-dimethylethyl ester, (2S,3R)-
Synonyma:
tert-butyl (2S,3R)-2,3-dimethylpiperazine-1-carboxylate;1-Piperazinecarboxylic acid, 2,3-dimethyl-, 1,1-dimethylethyl ester, (2S,3R)-
CBNumber:
CB38134153
Summenformel:
C11H22N2O2
Molgewicht:
214.3
MOL-Datei:
1932164-94-7.mol
Request For Quotation

1-Piperazinecarboxylic acid, 2,3-dimethyl-, 1,1-dimethylethyl ester, (2S,3R)- Eigenschaften

Siedepunkt:
279.7±15.0 °C(Predicted)
Dichte
0.970±0.06 g/cm3(Predicted)
pka
8.55±0.60(Predicted)

Sicherheit

1-Piperazinecarboxylic acid, 2,3-dimethyl-, 1,1-dimethylethyl ester, (2S,3R)- Chemische Eigenschaften,Einsatz,Produktion Methoden

1-Piperazinecarboxylic acid, 2,3-dimethyl-, 1,1-dimethylethyl ester, (2S,3R)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1-Piperazinecarboxylic acid, 2,3-dimethyl-, 1,1-dimethylethyl ester, (2S,3R)- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 6)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Suzhou ARTK Medchem Co., Ltd. 		+8618168183658
 sales1@artkmedchem.com China 39009 58
Jiangsu yize medical technology co. LTD 18550739526
 23903480@qq.com China 5841 58
Jiangsu yize medical technology co. LTD 18962082606
 3394205705@qq.com China 9773 58
Shanghai Ruipu Medical Technology Co., Ltd 15895968936
 1018762393@qq.com China 10000 58
PharmaBlock Sciences (Nanjing), Inc. 025-86918232 4000255188
 sales_china@pharmablock.com China 9792 58
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. 025-66113011 18112977050
 cb5@aikonchem.com China 10529 58
  • 1-Piperazinecarboxylic acid, 2,3-dimethyl-, 1,1-dimethylethyl ester, (2S,3R)-
  • tert-butyl (2S,3R)-2,3-dimethylpiperazine-1-carboxylate
  • 1932164-94-7
Copyright 2019 © ChemicalBook. All rights reserved